From Radiology to Drug Discovery, Survey Reveals AI Is Delivering Clear Return on Investment in Healthcare

NVIDIA's second annual 'State of AI in Healthcare and Life Sciences' survey shows the industry has moved from AI experimentation to execution. Key findings: 70% of organizations are actively using AI (up from 63% in 2024), 69% are using generative AI and LLMs (up from 54%), and 85% of executives report AI is increasing revenue while 80% say it reduces costs. Medical imaging, drug discovery, clinical decision support, and administrative workflow optimization are the top ROI-generating use cases. Open source AI models are considered important by 82% of respondents, and 47% are already using or evaluating agentic AI. AI budgets are set to increase for 85% of organizations, with nearly half planning increases of more than 10%.